Ivy Hansen
Medical · Idaho Falls, IDNPI 1164755104
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.0% of the total across 99 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 57.6% of the total. Reporting peaked in 2021 at $541 and has fallen 72.5% since, to $149 in 2025.
Across 99 payments — averaging $18.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Astellas Pharma US Inc$217
- Shield Therapeutics Inc$72
- Exeltis, USA Inc.$68
- Amgen$65
- Biohaven Pharmaceutical Holding Company Ltd.$50
- plus $308 from 14 others
What the payments were for
- Food & beverage$1,74895%
- Education$925%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 57 | $1,061 |
| Astellas Pharma US Inc | 6 | $217 |
| Shield Therapeutics Inc | 4 | $72 |
| Exeltis, USA Inc. | 4 | $68 |
| Amgen | 4 | $65 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $50 |
| Lilly USA, LLC | 3 | $39 |
| Scynexis, Inc. | 2 | $37 |
| Biohaven Pharmaceuticals, Inc. | 3 | $37 |
| Hologic Sales And Service, LLC | 2 | $24 |
| Aspira Women's Health Inc | 1 | $23 |
| Pfizer | 1 | $20 |
| Novo Nordisk | 1 | $20 |
| Merck | 1 | $18 |
| Boston Scientific | 1 | $17 |
| BD | 1 | $16 |
| Organon | 1 | $16 |
| Axonics, Inc. | 1 | $15 |
| Exact Sciences | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $13 |
How this compares
$1,840 in reported general payments places this provider in the 80th percentile of 265 medical providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxybutynin Chloride ErOxybutynin Chloride | 42 | $2,000 |
| Levothyroxine Sodium | 154 | $1,007 |
| Alendronate Sodium | 124 | $715 |
| Bupropion XlBupropion Hcl | 22 | $516 |
| Gabapentin | 24 | $512 |
| Simvastatin | 101 | $457 |
| Duloxetine Hcl | 20 | $404 |
| Sertraline Hcl | 51 | $375 |
| Omeprazole | 33 | $369 |
| Medroxyprogesterone Acetate | 11 | $348 |
| Citalopram HbrCitalopram Hydrobromide | 65 | $279 |
| Metformin Hcl ErMetformin Hcl | 63 | $217 |
| Escitalopram Oxalate | 21 | $207 |
| Losartan Potassium | 39 | $172 |
| Paroxetine Hcl | 15 | $166 |
Paid to pharmacies, not to this prescriber.
Other medical in Idaho Falls
- Jed BartschiIdaho Falls$11K
- Weldon RichardsonIdaho Falls$8K
- Wade ChristensenIdaho Falls$8K
- Joshua HansenIdaho Falls$8K
- Cameron FrenchIdaho Falls$5K
- Brandon LarsenIdaho Falls$5K
- Rebecca WestergardIdaho Falls$4K
- Shelley DavisIdaho Falls$4K
- Alyssa JenkinsIdaho Falls$3K
- William UlrichIdaho Falls$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.